Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Yttrium-90 or Rhenium-186 Synoviorthesis
NCT01615991Phase 3Completed
- Sponsor
- Centre de recherche du CHUS
- Start
- May 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of yttrium-90 citrate colloid and rhenium-186 sulfide in synovitis and arthritis, sponsored by Centre de recherche du CHUS. Primary endpoint: Safety. Started May 2012; status: completed.
02
Drugs
yttrium-90 citrate colloidrhenium-186 sulfide
03
Conditions
synovitisarthritis
Beyond the preview
Go deeper on NCT01615991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615991.